Validation of four AIDS-case definitions in HIV-infected intravenous drug users in Barcelona, Spain

Detalhes bibliográficos
Autor(a) principal: Miranda,Paulo Sérgio C.
Data de Publicação: 1998
Outros Autores: Marco,Andrés, Caylà,Joan Arthur, Galdós-Tangüis,Hernando, García de Olalla,Patricia
Tipo de documento: Artigo
Idioma: eng
Título da fonte: Revista brasileira de epidemiologia (Online)
Texto Completo: http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X1998000200007
Resumo: The objective of the study is to assess the sensitivity and specificity of four epidemiological AIDS-Case Definitions (CDC-87, CDC-93, Europe-93 and Revised Caracas) in HIV-infected intravenous drug users (IDU). The authors carried out a cross-sectional study with 136 IDUs, HIV-infected from a Men Penitentiary Center and from a drug addiction treatment center of Barcelona, Spain, between October/93 and April/94. A protocol, including demographic, clinical and laboratory variables was used by one doctor and the laboratory tests were done in the same institution. After that, the patients were classified in the four Epidemiological AIDS-Case Definitions used by this study. As gold standard we used the CD4 Cell Count (out point 200 or 14% CD4+). The number of AIDS cases varied between 31 and 84 according to the type of AIDS definition. The CDC-93 AIDS definition implied an increase of 170.9% in the number of cases in relation to CDC-87 AIDS-Case Definition. The sensitivities of the CDC-87, CDC-93, Europe-93 and Revised Caracas Epidemiological AIDS - Case Definitions were 34.2, 88.6, 45.6 and 56.9% while the specificities were 93.0, 75.4, 75.4 and 77.2%, respectively. The positive predictive values were between 72.0% (Europe-93) and 87.1% (CDC-87) and the negative predictive values were between 50.0% (Europe-93) and 82.7% (CDC-93). The authors concluded: the sensitivity and specificity of Caracas Revised Epidemiological AIDS-Case Definition was better than Europe-93 AIDS Case Definition. So this Definition can be very useful in countries and situations where the CD4 Cell Count is not available for technical or economical reasons.
id ABRASCO-1_1fd121bb71c32f3c0ed1fdeef3b431d4
oai_identifier_str oai:scielo:S1415-790X1998000200007
network_acronym_str ABRASCO-1
network_name_str Revista brasileira de epidemiologia (Online)
repository_id_str
spelling Validation of four AIDS-case definitions in HIV-infected intravenous drug users in Barcelona, SpainAcquired Immunodeficiency Syndrome, epidemiologySubstance abuse, intravenousEpidemiologic research designSensitivity and specificitySpainThe objective of the study is to assess the sensitivity and specificity of four epidemiological AIDS-Case Definitions (CDC-87, CDC-93, Europe-93 and Revised Caracas) in HIV-infected intravenous drug users (IDU). The authors carried out a cross-sectional study with 136 IDUs, HIV-infected from a Men Penitentiary Center and from a drug addiction treatment center of Barcelona, Spain, between October/93 and April/94. A protocol, including demographic, clinical and laboratory variables was used by one doctor and the laboratory tests were done in the same institution. After that, the patients were classified in the four Epidemiological AIDS-Case Definitions used by this study. As gold standard we used the CD4 Cell Count (out point 200 or 14% CD4+). The number of AIDS cases varied between 31 and 84 according to the type of AIDS definition. The CDC-93 AIDS definition implied an increase of 170.9% in the number of cases in relation to CDC-87 AIDS-Case Definition. The sensitivities of the CDC-87, CDC-93, Europe-93 and Revised Caracas Epidemiological AIDS - Case Definitions were 34.2, 88.6, 45.6 and 56.9% while the specificities were 93.0, 75.4, 75.4 and 77.2%, respectively. The positive predictive values were between 72.0% (Europe-93) and 87.1% (CDC-87) and the negative predictive values were between 50.0% (Europe-93) and 82.7% (CDC-93). The authors concluded: the sensitivity and specificity of Caracas Revised Epidemiological AIDS-Case Definition was better than Europe-93 AIDS Case Definition. So this Definition can be very useful in countries and situations where the CD4 Cell Count is not available for technical or economical reasons.Associação Brasileira de Saúde Coletiva1998-08-01info:eu-repo/semantics/articleinfo:eu-repo/semantics/publishedVersiontext/htmlhttp://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X1998000200007Revista Brasileira de Epidemiologia v.1 n.2 1998reponame:Revista brasileira de epidemiologia (Online)instname:Associação Brasileira de Saúde Coletiva (ABRASCO)instacron:ABRASCO10.1590/S1415-790X1998000200007info:eu-repo/semantics/openAccessMiranda,Paulo Sérgio C.Marco,AndrésCaylà,Joan ArthurGaldós-Tangüis,HernandoGarcía de Olalla,Patriciaeng2005-08-04T00:00:00Zoai:scielo:S1415-790X1998000200007Revistahttp://www.scielo.br/rbepidhttps://old.scielo.br/oai/scielo-oai.php||revbrepi@usp.br1980-54971415-790Xopendoar:2005-08-04T00:00Revista brasileira de epidemiologia (Online) - Associação Brasileira de Saúde Coletiva (ABRASCO)false
dc.title.none.fl_str_mv Validation of four AIDS-case definitions in HIV-infected intravenous drug users in Barcelona, Spain
title Validation of four AIDS-case definitions in HIV-infected intravenous drug users in Barcelona, Spain
spellingShingle Validation of four AIDS-case definitions in HIV-infected intravenous drug users in Barcelona, Spain
Miranda,Paulo Sérgio C.
Acquired Immunodeficiency Syndrome, epidemiology
Substance abuse, intravenous
Epidemiologic research design
Sensitivity and specificity
Spain
title_short Validation of four AIDS-case definitions in HIV-infected intravenous drug users in Barcelona, Spain
title_full Validation of four AIDS-case definitions in HIV-infected intravenous drug users in Barcelona, Spain
title_fullStr Validation of four AIDS-case definitions in HIV-infected intravenous drug users in Barcelona, Spain
title_full_unstemmed Validation of four AIDS-case definitions in HIV-infected intravenous drug users in Barcelona, Spain
title_sort Validation of four AIDS-case definitions in HIV-infected intravenous drug users in Barcelona, Spain
author Miranda,Paulo Sérgio C.
author_facet Miranda,Paulo Sérgio C.
Marco,Andrés
Caylà,Joan Arthur
Galdós-Tangüis,Hernando
García de Olalla,Patricia
author_role author
author2 Marco,Andrés
Caylà,Joan Arthur
Galdós-Tangüis,Hernando
García de Olalla,Patricia
author2_role author
author
author
author
dc.contributor.author.fl_str_mv Miranda,Paulo Sérgio C.
Marco,Andrés
Caylà,Joan Arthur
Galdós-Tangüis,Hernando
García de Olalla,Patricia
dc.subject.por.fl_str_mv Acquired Immunodeficiency Syndrome, epidemiology
Substance abuse, intravenous
Epidemiologic research design
Sensitivity and specificity
Spain
topic Acquired Immunodeficiency Syndrome, epidemiology
Substance abuse, intravenous
Epidemiologic research design
Sensitivity and specificity
Spain
description The objective of the study is to assess the sensitivity and specificity of four epidemiological AIDS-Case Definitions (CDC-87, CDC-93, Europe-93 and Revised Caracas) in HIV-infected intravenous drug users (IDU). The authors carried out a cross-sectional study with 136 IDUs, HIV-infected from a Men Penitentiary Center and from a drug addiction treatment center of Barcelona, Spain, between October/93 and April/94. A protocol, including demographic, clinical and laboratory variables was used by one doctor and the laboratory tests were done in the same institution. After that, the patients were classified in the four Epidemiological AIDS-Case Definitions used by this study. As gold standard we used the CD4 Cell Count (out point 200 or 14% CD4+). The number of AIDS cases varied between 31 and 84 according to the type of AIDS definition. The CDC-93 AIDS definition implied an increase of 170.9% in the number of cases in relation to CDC-87 AIDS-Case Definition. The sensitivities of the CDC-87, CDC-93, Europe-93 and Revised Caracas Epidemiological AIDS - Case Definitions were 34.2, 88.6, 45.6 and 56.9% while the specificities were 93.0, 75.4, 75.4 and 77.2%, respectively. The positive predictive values were between 72.0% (Europe-93) and 87.1% (CDC-87) and the negative predictive values were between 50.0% (Europe-93) and 82.7% (CDC-93). The authors concluded: the sensitivity and specificity of Caracas Revised Epidemiological AIDS-Case Definition was better than Europe-93 AIDS Case Definition. So this Definition can be very useful in countries and situations where the CD4 Cell Count is not available for technical or economical reasons.
publishDate 1998
dc.date.none.fl_str_mv 1998-08-01
dc.type.driver.fl_str_mv info:eu-repo/semantics/article
dc.type.status.fl_str_mv info:eu-repo/semantics/publishedVersion
format article
status_str publishedVersion
dc.identifier.uri.fl_str_mv http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X1998000200007
url http://old.scielo.br/scielo.php?script=sci_arttext&pid=S1415-790X1998000200007
dc.language.iso.fl_str_mv eng
language eng
dc.relation.none.fl_str_mv 10.1590/S1415-790X1998000200007
dc.rights.driver.fl_str_mv info:eu-repo/semantics/openAccess
eu_rights_str_mv openAccess
dc.format.none.fl_str_mv text/html
dc.publisher.none.fl_str_mv Associação Brasileira de Saúde Coletiva
publisher.none.fl_str_mv Associação Brasileira de Saúde Coletiva
dc.source.none.fl_str_mv Revista Brasileira de Epidemiologia v.1 n.2 1998
reponame:Revista brasileira de epidemiologia (Online)
instname:Associação Brasileira de Saúde Coletiva (ABRASCO)
instacron:ABRASCO
instname_str Associação Brasileira de Saúde Coletiva (ABRASCO)
instacron_str ABRASCO
institution ABRASCO
reponame_str Revista brasileira de epidemiologia (Online)
collection Revista brasileira de epidemiologia (Online)
repository.name.fl_str_mv Revista brasileira de epidemiologia (Online) - Associação Brasileira de Saúde Coletiva (ABRASCO)
repository.mail.fl_str_mv ||revbrepi@usp.br
_version_ 1754212950123479040